Molecular Diagnostics and NAT market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics and NAT market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Molecular Diagnostics and NAT market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Segment by Application
Hospitals and Clinics
Research Institutes
Diagnostic Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
